Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16130-58-8

Post Buying Request

16130-58-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16130-58-8 Usage

Description

Acetyl chloride, cyano-, also known as Cyanoacetyl chloride, is an organic compound with the chemical formula ClC(O)CH2CN. It is a derivative of acetyl chloride, featuring a cyano group (CN) attached to the acetyl moiety. Acetyl chloride, cyanois known for its reactivity and is commonly used in the synthesis of various organic compounds.

Uses

Used in Pharmaceutical Industry:
Acetyl chloride, cyanois used as a synthetic intermediate for the preparation of butadiene derivatives containing benzo[b]furo[3,2-d][1,3]oxazine. These derivatives have demonstrated anti-osteoclastic bone resorption activity, which is crucial for the development of treatments targeting bone-related disorders and conditions.
Used in Biochemical Research:
In the field of biochemical research, Acetyl chloride, cyanois used to study the antagonistic activity for the cysLT1 receptor. The cysLT1 receptor plays a significant role in various biological processes, and understanding its interactions can lead to the development of new therapeutic strategies for related diseases.
Used in Cancer Research:
Acetyl chloride, cyanois also utilized in the development of compounds with growth inhibitory activity for cancer cell lines such as MIA PaCa-2 (pancreatic cancer) and MCF-7 (breast cancer). These compounds can potentially be used in the development of novel anticancer drugs, contributing to the fight against cancer and improving patient outcomes.

Check Digit Verification of cas no

The CAS Registry Mumber 16130-58-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,1,3 and 0 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 16130-58:
(7*1)+(6*6)+(5*1)+(4*3)+(3*0)+(2*5)+(1*8)=78
78 % 10 = 8
So 16130-58-8 is a valid CAS Registry Number.

16130-58-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Cyanoacetyl chloride

1.2 Other means of identification

Product number -
Other names chlorine carbon monoxide radical

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16130-58-8 SDS

16130-58-8Synthetic route

cyanoacetic acid
372-09-8

cyanoacetic acid

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

Conditions
ConditionsYield
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 0.5h; Solvent; Temperature; Inert atmosphere;100%
With phosphorus pentachloride In diethyl ether at 20℃;89%
With phosphorus pentachloride In diethyl ether Inert atmosphere; Cooling with ice;52%
oxalyl dichloride
79-37-8

oxalyl dichloride

cyanoacetic acid
372-09-8

cyanoacetic acid

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

Conditions
ConditionsYield
In dichloromethane; N,N-dimethyl-formamide
In dichloromethane; N,N-dimethyl-formamide at 20℃; for 2.5h;
cyanoacetic acid
372-09-8

cyanoacetic acid

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

Conditions
ConditionsYield
With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 25℃; for 1h; Inert atmosphere;
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

cis-1-<1-<(tert-Butyldimethylsiloxy)methyl>-2-hydroxy-4-methyl-3-cyclohexenyl>-1-ethanone
75233-82-8

cis-1-<1-<(tert-Butyldimethylsiloxy)methyl>-2-hydroxy-4-methyl-3-cyclohexenyl>-1-ethanone

Cyano-acetic acid (1R,6R)-6-acetyl-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-methyl-cyclohex-2-enyl ester
75247-62-0

Cyano-acetic acid (1R,6R)-6-acetyl-6-(tert-butyl-dimethyl-silanyloxymethyl)-3-methyl-cyclohex-2-enyl ester

Conditions
ConditionsYield
With pyridine In diethyl ether; dichloromethane at 0℃; for 0.25h;100%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

5-bromo-2-aminobenzoic acid methyl ester
52727-57-8

5-bromo-2-aminobenzoic acid methyl ester

methyl 2-(2-cyanoacetamido)-5-bromobenzoate
1179347-38-6

methyl 2-(2-cyanoacetamido)-5-bromobenzoate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;100%
2-amino-4-(2-phenyl-cyclopropyl)-thiophene-3-carboxylic acid ethyl ester
844501-14-0

2-amino-4-(2-phenyl-cyclopropyl)-thiophene-3-carboxylic acid ethyl ester

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

2-(2-cyano-acetylamino)-4-(2-phenyl-cyclopropyl)-thiophene-3-carboxylic acid ethyl ester
844501-16-2

2-(2-cyano-acetylamino)-4-(2-phenyl-cyclopropyl)-thiophene-3-carboxylic acid ethyl ester

Conditions
ConditionsYield
In dichloromethane99%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

C17H19NO3

C17H19NO3

C20H18N2O3

C20H18N2O3

Conditions
ConditionsYield
In benzene at 80℃; for 24h; Inert atmosphere;98%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

C16H16BrNO2

C16H16BrNO2

C19H15BrN2O2

C19H15BrN2O2

Conditions
ConditionsYield
In benzene at 80℃; for 24h; Inert atmosphere;98%
1-[5-chloro-2-(4-methoxy-benzylamino)-phenyl]-ethanone
685540-89-0

1-[5-chloro-2-(4-methoxy-benzylamino)-phenyl]-ethanone

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

C19H15ClN2O2

C19H15ClN2O2

Conditions
ConditionsYield
In benzene at 80℃; for 24h; Inert atmosphere;97%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

1-(2-((4-methoxybenzyl)amino)phenyl)propan-1-one

1-(2-((4-methoxybenzyl)amino)phenyl)propan-1-one

3-cyano-4-ethyl-2-quinolone

3-cyano-4-ethyl-2-quinolone

Conditions
ConditionsYield
In benzene at 80℃; for 12h; Inert atmosphere;97%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

(2R,5R)-2,5-Bis(methoxymethoxymethyl)pyrrolidine
90290-06-5

(2R,5R)-2,5-Bis(methoxymethoxymethyl)pyrrolidine

(2R,5R)-N-cyanoacetyl-2,5-bis(meyhoxymethoxymethyl)pyrrolidine
108138-88-1

(2R,5R)-N-cyanoacetyl-2,5-bis(meyhoxymethoxymethyl)pyrrolidine

Conditions
ConditionsYield
In dichloromethane Ambient temperature;96%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose
4064-06-6

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose

Cyano-acetic acid (3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyl-tetrahydro-bis[1,3]dioxolo[4,5-b;4',5'-d]pyran-5-ylmethyl ester
132640-93-8

Cyano-acetic acid (3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyl-tetrahydro-bis[1,3]dioxolo[4,5-b;4',5'-d]pyran-5-ylmethyl ester

Conditions
ConditionsYield
With silver cyanide In toluene at 80℃; for 4h;96%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

(-)-menthol
2216-51-5

(-)-menthol

(1R,2S,5R)-cyanoacetic acid 2-isopropyl-5-methylcyclohexyl ester
54082-39-2

(1R,2S,5R)-cyanoacetic acid 2-isopropyl-5-methylcyclohexyl ester

Conditions
ConditionsYield
With silver cyanide In toluene at 80℃; for 4h;95%
With N,N-dimethyl-aniline In diethyl ether
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

2,5-dimethoxyaniline
102-56-7

2,5-dimethoxyaniline

2,5-dimethoxy-cyanoacetanilide
113604-07-2

2,5-dimethoxy-cyanoacetanilide

Conditions
ConditionsYield
With triethylamine In dichloromethane95%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

N,N-Dicyclohexyl-C-((1R,2R,4S)-2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-yl)-methanesulfonamide
501445-38-1

N,N-Dicyclohexyl-C-((1R,2R,4S)-2-hydroxy-7,7-dimethyl-bicyclo[2.2.1]hept-1-yl)-methanesulfonamide

Cyano-acetic acid (1R,2R,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester
132640-89-2

Cyano-acetic acid (1R,2R,4S)-1-[(dicyclohexylsulfamoyl)-methyl]-7,7-dimethyl-bicyclo[2.2.1]hept-2-yl ester

Conditions
ConditionsYield
With silver cyanide In toluene at 80℃; for 4h;93%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

(-)-8-phenylmenthol
65253-04-5

(-)-8-phenylmenthol

Cyano-acetic acid (1R,2S,5R)-5-methyl-2-(1-methyl-1-phenyl-ethyl)-cyclohexyl ester
132640-90-5

Cyano-acetic acid (1R,2S,5R)-5-methyl-2-(1-methyl-1-phenyl-ethyl)-cyclohexyl ester

Conditions
ConditionsYield
With silver cyanide In toluene at 80℃; for 4h;92%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

C8H14N2O2

C8H14N2O2

C10H15N3O2

C10H15N3O2

Conditions
ConditionsYield
Stage #1: C8H14N2O2 With aluminum (III) chloride; lithium aluminium tetrahydride In diethyl ether at 20 - 30℃; for 0.5h;
Stage #2: cyanoacetic acid chloride In pyridine; dichloromethane at 20 - 30℃; for 10h; Concentration;
92%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

C17H19NO2

C17H19NO2

C20H18N2O2

C20H18N2O2

Conditions
ConditionsYield
In benzene at 80℃; for 24h; Inert atmosphere;91%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

4-heptadecafluorooctylaniline
83766-52-3

4-heptadecafluorooctylaniline

C17H7F17N2O

C17H7F17N2O

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0℃;91%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

N-(R-2-chloro-propyl)-2-aminoacetic acid tertbutyl ester

N-(R-2-chloro-propyl)-2-aminoacetic acid tertbutyl ester

tert-butyl 2-{N-[(2R)-2-chloropropyl]-2-cyanoacetamido}acetate

tert-butyl 2-{N-[(2R)-2-chloropropyl]-2-cyanoacetamido}acetate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 30 - 35℃; for 4h;90.5%
With triethylamine In dichloromethane at 30 - 35℃; for 4h;90.5%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

N-(R-2-chloropropyl)-2-aminoacetamide

N-(R-2-chloropropyl)-2-aminoacetamide

N-(R-2-chloropropyl)-N-(2-acetamido)-2-cyanoacetamide

N-(R-2-chloropropyl)-N-(2-acetamido)-2-cyanoacetamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 30 - 35℃; for 4h;89.1%
2,5-DIMETHYLTHIOPHENE
638-02-8

2,5-DIMETHYLTHIOPHENE

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

3-(2,5-dimethyl-thiophen-3-yl)-3-oxo-propionitrile
608522-55-0

3-(2,5-dimethyl-thiophen-3-yl)-3-oxo-propionitrile

Conditions
ConditionsYield
With aluminium trichloride In dichloromethane at 0℃; for 1h;89%
1-[5-chloro-2-(4-methoxy-benzylamino)-phenyl]-pentan-1-one
903594-22-9

1-[5-chloro-2-(4-methoxy-benzylamino)-phenyl]-pentan-1-one

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

4-butyl-6-chloro-1-(4-methoxy-benzyl)-2-oxo-1,2-dihydro-quinoline-3-carbonitrile
903594-66-1

4-butyl-6-chloro-1-(4-methoxy-benzyl)-2-oxo-1,2-dihydro-quinoline-3-carbonitrile

Conditions
ConditionsYield
In benzene at 80℃; for 2h;89%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

C17H19NO2

C17H19NO2

C20H18N2O2

C20H18N2O2

Conditions
ConditionsYield
In benzene at 80℃; for 24h; Inert atmosphere;88%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

2-isopropylaniline
643-28-7

2-isopropylaniline

2-cyano-N-[2-(isopropyl)phenyl]acetamide
87165-41-1

2-cyano-N-[2-(isopropyl)phenyl]acetamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 3h;88%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

2-((R)-2-chloropropylamino)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)acetamide

2-((R)-2-chloropropylamino)-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)acetamide

C14H15ClN6O2

C14H15ClN6O2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 40 - 45℃; for 6h;87.2%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

methyl 3-amino-3-(4-butoxyphenyl)butanoate
1441058-80-5

methyl 3-amino-3-(4-butoxyphenyl)butanoate

methyl 3-(4-butoxyphenyl)-3-(2-cyanoacetamido)butanoate
1441058-82-7

methyl 3-(4-butoxyphenyl)-3-(2-cyanoacetamido)butanoate

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 5h;87%
methyl-[7-(toluene-4-sulfonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-amine
910789-32-1

methyl-[7-(toluene-4-sulfonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-amine

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

C6H12BrN

C6H12BrN

3-((3R,4R)-4-methyl-3-(methyl(7-p-toluenesulfonyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-yl)-3-oxopropionitrile

3-((3R,4R)-4-methyl-3-(methyl(7-p-toluenesulfonyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-yl)-3-oxopropionitrile

Conditions
ConditionsYield
Stage #1: methyl-[7-(toluene-4-sulfonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-amine; C6H12BrN With monophosphine 1,2,3,4,5-pentaphenyl-1'-(di-tert-butylphosphino)ferrocene; potassium tert-butylate; lead(II) chloride In 1,4-dioxane at 20℃; for 5h; Inert atmosphere;
Stage #2: cyanoacetic acid chloride With pyridine at 20 - 30℃; for 10h; Reagent/catalyst; Solvent;
87%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

1-(3-amino-7-methoxy-benzofuran-2-yl)-ethanone
916329-09-4

1-(3-amino-7-methoxy-benzofuran-2-yl)-ethanone

N-(2-acetyl-7-methoxy-benzofuran-3-yl)-2-cyano-acetamide

N-(2-acetyl-7-methoxy-benzofuran-3-yl)-2-cyano-acetamide

Conditions
ConditionsYield
In tetrahydrofuran at 68℃; for 6h;86%
1,2:5,6-di-O-isopropylidene-α-D-glucofuranose
350255-13-9

1,2:5,6-di-O-isopropylidene-α-D-glucofuranose

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

Cyano-acetic acid (3aR,5R,6S,6aR)-5-(2,2-dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl ester
132640-91-6

Cyano-acetic acid (3aR,5R,6S,6aR)-5-(2,2-dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl ester

Conditions
ConditionsYield
With silver cyanide In toluene at 80℃; for 4h;85%
cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

ethyl 2-(3-(4-methoxyphenylamino)-3-oxopropanamido)-2-methyl-4-oxo-4-p-tolylbutanoate
1441058-46-3

ethyl 2-(3-(4-methoxyphenylamino)-3-oxopropanamido)-2-methyl-4-oxo-4-p-tolylbutanoate

ethyl 2-(2-cyanoacetamido)-2-methyl-4-oxo-4-p-tolylbutanoate
1441058-88-3

ethyl 2-(2-cyanoacetamido)-2-methyl-4-oxo-4-p-tolylbutanoate

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 20℃; for 1h; Inert atmosphere;84%
1,3-dibromo-2-hydroxypropane
96-21-9

1,3-dibromo-2-hydroxypropane

cyanoacetic acid chloride
16130-58-8

cyanoacetic acid chloride

2-bromo-1-(bromomethyl)ethyl cyanoacetate

2-bromo-1-(bromomethyl)ethyl cyanoacetate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane Inert atmosphere;83%

16130-58-8Relevant articles and documents

Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors

Hou, Weijie,Sun, Huan,Ma, Yongfen,Liu, Chunyan,Zhang, Zhiyuan

, p. 5901 - 5919 (2019)

In the course of developing the biochemistry to chemistry activity-based protein profiling (BTC-ABPP) method, we herein unexpectedly discovered that the epidermal growth factor receptor irreversible inhibitor WZ4002 also functioned as a low micromolar inhibitor of cathepsin C (CatC), a promising target for the treatment of numerous inflammatory and autoimmune diseases. Building on from this discovery, and following structure-activity relationship investigations guided by computational modeling, a novel series of pyridine scaffold compounds were developed as irreversible CatC inhibitors, further culminated in identifying a highly potent and selective inhibitor 22, which displays good metabolic stability and oral bioavailability. In vivo studies revealed that compound 22 clearly displays the ability to inhibit CatC, consequently leading to efficient inhibition of downstream neutrophil serine proteases in both bone marrow and blood. The overall excellent profile of compound 22 made it an interesting candidate for further preclinical investigation.

Quantification of CH...π interactions: Implications on how substituent effects influence aromatic interactions

Gung, Benjamin W.,Emenike, Bright U.,Lewis, Michael,Kirschbaum, Kristin

, p. 12357 - 12362 (2010)

Attractive interactions between a substituted benzene ring and an α-substituted acetate group were determined experimentally by using the triptycene model system. The attractive interaction correlates well with the Hammett constants σm (R2=0.90), but correlates much better with the acidity of the α-protons (R2=0.98). A predominant CH...π interaction was found to control the conformational preference of model compounds 1a-g. Despite the predominance of the CH...π interaction in compounds 1a-g, a Hammett plot displays a fairly straight line for the substituent effect. These results show that when using Hammett plots in a simplified model system, a system designed to study the effect of X...π interactions could capture the X-H...π interaction instead.

Stable enols of amides ArNHC(OH)=C(CN)CO2R. E/Z enols, equilibria with the amides, solvent effects, and hydrogen bonding

Lei, Yi Xiong,Casarini, Daniele,Cerioni, Giovanni,Rappoport, Zvi

, p. 947 - 959 (2003)

The structures of anilido cyano(fluoroalkoxycarbonyl)methanes ArNHCOCH(CN)CO2R, where r = CH2CF3 or CH(CF3)2, Ar = p-XC6H4, and X = MeO, Me, H, or Br, were investigated. In the solid state, all exist as the enols ArNHC(OH)=C(CN)CO2R 7 (R = CH2CF3) and 9 (R = CH(CF3)2) with cis arrangement of the hydrogen-bonded ROC=O...HO moiety and a long C1=C2 bond. The product composition in solution is solvent dependent. In CDCl3 solution, only a single enol is observed, whereas in THF-d8 and CD3CN, two enols (E and Z) are the major products, and the amide is the minor product or not observed at all (KEnol 1.04-9 (CD3CN, 298 K) and 3 to ≥100 (THF, 300 K)). The percentage of the amide and the Z-enol increase upon an increase in temperature. In all solvents, the percent enol is higher for 9 than for 7. In CD3CN, more enol is observed when the aryl group is more electron-donating. The spectra in DMSO-d6 and DMF-d7 indicate the presence of mostly a single species, whose spectra do not change on addition of a base and is ascribed to the anion of the ionized carbon acid. Comparison with systems where the CN is replaced by a CO2R group (R = CH2CF3, CH(CF3)2) shows a higher percentage of enol for the CN-substituted system. Intramolecular (to CO2R) and intermolecular hydrogen bonds determine, to a significant extent, the stability of the enols, their Z/E ratios (e.g., Z/E (THF, 240 K) = 3.2-4.0 (7) and 0.9-1.3 (9)), and their δ(OH) in the 1H spectra. The interconversion of Z- and E-enol by rotation around the C=C bond was studied by DNMR, and ΔG? values of ≥15.3 and 14.1 ± 0.4 kcal/mol for Z-7 and Z-9 were determined. Features of the NMR spectra of the enols and their anions are discussed.

Cyanoketene: The microwave spectrum and structure of an unstable molecule

Hahn,Bodenseh,Ferner

, p. 138 - 147 (2004)

The unstable molecule cyanoketene has been prepared by pyrolysis in a flow system, and the microwave spectra of five isotopic species, a- and b-type, have been measured in the frequency range from 8 to 40 GHz. Precise rotational constants and centrifugal distortion parameters up to the sixth order were obtained. The molecule has been shown to be planar, and a reliable structure was derived, Also the N-quadrupole coupling constants and the dipole moment components have been determined. The results could be a basis for interstellar spectroscopy of this molecule.

KRAS MUTANT PROTEIN INHIBITORS

-

Paragraph 0201; 0203, (2021/04/02)

The invention relates to a KRAS mutant protein inhibitor, a composition containing the inhibitor and the use thereof.

KRAS MUTANT PROTEIN INHIBITORS

-

Page/Page column 38-39, (2021/06/26)

The invention relates to a KRAS mutant protein inhibitor shown as formula (I), a composition containing the inhibitor and the use thereof.

Fused pyrimidine derivative, and preparation method thereof and application of fused pyrimidine derivative in medicine

-

Paragraph 0271-0276, (2021/07/21)

The invention relates to a fused pyrimidine derivative, and a preparation method thereof and application of the fused pyrimidine derivative in medicine. Specifically, the invention relates to a fused pyrimidine derivative shown in a general formula (I), a preparation method of the fused pyrimidine derivative, a pharmaceutical composition containing the derivative and application of the fused pyrimidine derivative as a therapeutic agent, especially application of the fused pyrimidine derivative as an ATR kinase inhibitor and application of the fused pyrimidine derivative in preparation of drugs for treating or preventing hyperproliferative diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16130-58-8